Shri Narendra Modi, Prime Minister, is the president of CSIR.
Dr. Jitendra Singh is the Hon’ble Union Minister for Ministry of Science & Technology and Ministry of Earth Sciences.
Dr. N Kalaiselvi is the Director General of CSIR.
Dr. Zabeer Ahmed is the Director of CSIR-IIIM.
Vision, Mission and Key objectives:-
Vision: The vision of the Institute is to position IIIM as an International center of excellence for natural products chemistry, chemical biology, pharmacology and bi otechnology to discover new chemical entities (NCEs) as drugs for unmet medical needs and provide scientific rationale and validity to various Indian systems of medicine. The institute aspires to achieve leadership position as a research Institute for creating a broad knowledge base, a work force of dedicated and trained scientists and a technology development center through scientific exploration of secondary metabolites from plants and microbial biodiversity, at the same time generating awareness for their conservation and protection.
Mission: To become a Centre of Excellence in Natural Products chemistry and biotechnology driven drug discovery, integrating modern biology with chemistry.
Function and duties:-
IIIM is to be an internationally competitive centre of excellence in all facets of natural products research and technology, including (a) discovery of novel pharmacologically active natural products from plants and microbial species and translating them into drug leads and candidates by medicinal chemistry, preclinical pharmacology and clinical development. This approach is pursued both in NCE as well as botanical herbal mode; (b) Preclinical and clinical validation and establishment of mechanism of action of drugs used in various Indian systems of Medicines (Ayurveda, Unani, Siddha and other Indigenous systems of medicine); (c) develop agro-technologies and commercial cultivation of high value medicinal and aromatic plants from Western Himalayas including Kashmir Valley and Ladakh for national and international markets; and (d) to work with Indian and global pharmaceutical industry to out-license new products and technologies.